IBREALEST2023-04-012023-06-30 IBREALEST2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member IBREALEST2023-06-30 IBREALEST2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532832 IBREALEST NOTLISTED Indiabulls Real Estate Limited Equity 2023-04-01 2024-03-31 2023-08-10 2023-08-04 INR Millions First quarter 14:00:00 15:50:00 2023-08-10 2023-08-10 Not applicable Single segment Real estate project in india 2023-04-01 2023-06-30 Unaudited Consolidated 1958700000.00 132300000.00 2091000000.00 1932000000.00 0.00 0.00 178600000.00 8200000.00 27400000.00 424500000.00 2570700000.00 -479700000.00 -6290700000.00 -6770400000.00 16800000.00 6200000.00 23000000.00 0.00 -6793400000.00 0.00 0.00 0.00 0.00 -6793400000.00 416200000.00 -6377200000.00 -6795500000.00 2100000.00 416200000.00 0.00 1082200000.00 2 -12.55 -12.55 0.00 0.00 -12.55 -12.55 Indiabulls Real Estate Limited ('the Company' or ‘the Holding Company’) and its subsidiaries are together referred as ‘the Group’ in the following notes. The Holding Company conducts its operations along with its subsidiaries. The consolidated financial results are prepared in accordance with the recognition and measurement principles of Indian Accounting Standards as notified under the Companies (Indian Accounting Standards) Rules, 2015 (as amended) as specified in Section 133 of the Companies Act, 2013. The consolidated financial results of the Group for the quarter ended 30 June 2023 have been reviewed by the Audit Committee and approved by the Board of Directors (’the Board’) at its meeting held on 10 August 2023. The results for the quarter have been subjected to limited review by the Statutory Auditors. Figures for the quarter ended 31 March 2023 represent the balancing figures between the audited figures for the full financial year and published reviewed year to date figures upto third quarter of the financial year. Exceptional item for the quarter ended 30 June 2023 includes impairment provision of Rs. 6,290.7 million (equivalent to GBP 61.85 million) shown as recoverable in one of the foreign subsidiaries of the Company, namely Brenformexa Limited. The management of the Company made a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. As a prudent measure, due to the uncertainty on the recoverability, a full provision has been created in the Books of Account of Brenformexa Limited. The above has been highlighted as an Emphasis of matter in the Auditors Limited Review Report on the consolidated financial results. Other expenses 424500000.00 Items that will not be reclassified to profit or loss 416200000.00 416200000.00 0.00 0.00